News Karnataka
Wednesday, February 01 2023
Health & Lifestyle

Cadila Healthcare gets USFDA nod for metronidazole tablets

Photo Credit :

Chennai: Pharma major Cadila Healthcare Ltd. on Monday said it has received the final approval from the US Food and Drug Administration (USFDA) to market metronidazole tablets.
In a regulatory filing with BSE, Cadila Healthcare said it has got USFDA’s approval to market metronidazole in strengths 250 mg and 500 mg tablets.

The drug is used to treat infections caused by bacteria or parasites.

According to Cadila Healthcare, the tablets will be made at the group’s formulations manufacturing facility at Baddi in Himachal Pradesh.

The company said the group now has more than 105 approvals and has so far filed nearly 275 ANDAs (Abbreviated New Drug Application) since the commencement of the filing process in FY 2003-04.

Share this:
MANY DROPS MAKE AN OCEAN
Support NewsKarnataka's quality independent journalism with a small contribution.

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Leave a Reply

Your email address will not be published. Required fields are marked *

Rohan City Corp
Rohan City Corp

Find the best odds at 10Cric and ipl betting 2021! Signup today and get up to a 100% deposit bonus.

To get the latest news on WhatsApp